Sweden
· Delayed Price · Currency is SEK Prolight Diagnostics AB Statistics
Total Valuation
Prolight Diagnostics AB has a market cap or net worth of SEK 124.83 million. The enterprise value is 92.44 million.
| Market Cap | 124.83M |
| Enterprise Value | 92.44M |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Prolight Diagnostics AB has 597.29 million shares outstanding. The number of shares has increased by 51.38% in one year.
| Shares Outstanding | 597.29M |
| Shares Change (YoY) | +51.38% |
| Shares Change (QoQ) | +5.49% |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 4.41% |
| Float | 548.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.55 |
| PB Ratio | 1.02 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.66 |
| EV / Sales | 3.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.79 |
Financial Position
The company has a current ratio of 1.57
| Current Ratio | 1.57 |
| Quick Ratio | 1.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -560.69 |
Financial Efficiency
Return on equity (ROE) is -89.89% and return on invested capital (ROIC) is -56.30%.
| Return on Equity (ROE) | -89.89% |
| Return on Assets (ROA) | -41.85% |
| Return on Capital (ROIC) | -56.30% |
| Revenue Per Employee | 1.57M |
| Profits Per Employee | -8.75M |
| Employee Count | 16 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.32% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -78.32% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 2,133,063 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Prolight Diagnostics AB had revenue of SEK 25.13 million and -140.00 million in losses. Loss per share was -0.33.
| Revenue | 25.13M |
| Gross Profit | 25.13M |
| Operating Income | -140.30M |
| Pretax Income | -140.00M |
| Net Income | -140.00M |
| EBITDA | -139.30M |
| EBIT | -140.30M |
| Loss Per Share | -0.33 |
Balance Sheet
| Cash & Cash Equivalents | 32.40M |
| Total Debt | n/a |
| Net Cash | 32.40M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 122.28M |
| Book Value Per Share | 0.20 |
| Working Capital | 12.92M |
Cash Flow
In the last 12 months, operating cash flow was -19.46 million and capital expenditures -4.91 million, giving a free cash flow of -24.38 million.
| Operating Cash Flow | -19.46M |
| Capital Expenditures | -4.91M |
| Free Cash Flow | -24.38M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -558.32% |
| Pretax Margin | -557.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -97.00% |
Dividends & Yields
Prolight Diagnostics AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -51.38% |
| Shareholder Yield | -51.38% |
| Earnings Yield | -159.91% |
| FCF Yield | -19.53% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |